CONTROLLED RELEASE FORMULATION OF WATER INSOLUBLE DRUG AND METHODS OF PREPARATION AND TREATMENT

摘要

An implant for use in method of treatment is disclosed whereby cancer cells are brought into contact with a formulation comprising an inhibitor of tyrosine kinase receptors. The formulation may be comprised of an injectable carrier and two or more tyrosine kinase receptor inhibitors which may be nordihydrogluaiaretic acid (NDGA) and doxyrubicine.